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Preventable disease burden  
and national health spending 
>75% of national health spending is attributable 
to chronic diseases that are largely preventable 
– 80% of cardiovascular disease 
– 80% of diabetes 
– 60% of lung diseases 
– 40% of cancers 
(not counting injuries, vaccine-preventable diseases) 
<3% of national health spending is allocated to 
public health and prevention 
CDC 2011 
Preventable mortality in the U.S. 
Preventable Deaths per 100,000 population 
Source: Commonwealth Fund 2008 
Geographic variation in preventable 
mortality 
Source: Commonwealth Fund 2008 
Public health activities 
Organized programs, policies, and laws to prevent disease 
and injury and promote health on a population-wide basis 
– Epidemiologic surveillance & investigation 
– Community health assessment & planning 
– Communicable disease control 
– Chronic disease prevention 
– Health education 
– Environmental health monitoring and assessment 
– Enforcement of health laws and regulations 
– Inspection and licensing 
– Inform, advise, and assist school-based, worksite-
based, and community-based health programming 
…and legacy of assuring access to medical care 
Public health’s share of national health spending 
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Factors driving growth in medical spending 
per case 
Roehrig et al. Health Affairs 2011 
Public Health in the Affordable Care Act 
 $15 billion in new federal public health spending 
over 10 years (cut by $5B in 2012 
 Public Health and Prevention Trust Fund  
 Incentives for hospitals, health insurers to 
invest in public health and prevention 
 
Some research questions of interest… 
 How does public health spending vary across 
communities and change over time? 
  What are the health effects attributable to 
changes in public health spending? 
 What are the medical cost effects attributable to 
changes in public health spending? 
The problem with public health spending 
 Federal & state funding sources often targeted to 
communities based in part on disease burden, risk, need 
 Local funding sources often dependent on local 
economic conditions that may also influence health 
 Public health spending may be correlated with other 
resources that influence health 
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Example: cross-sectional association 
between PH spending and mortality 
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Example: cross-sectional association 
between PH spending and Medical spending 
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Analyzing spending effects 
1. Cross-sectional regression: control for observable confounders 
2. Fixed effects: also control for time-invariant, unmeasured 
differences between communities 
3. IV: use exogenous sources of variation in spending 
4. Discriminate between causes of death amenable vs. non-
amendable to PH intervention 
PH spending 
Mortality 
Medical $ 
Unmeasured  
disease burden, 
risk 
Unmeasured  
economic  
conditions 
+ + 
+ _ 
Approaches 
Data used in empirical work 
 NACCHO Profile: financial and institutional data collected on 
the national population of local public health agencies 
(N≈2800) in 1993, 1997, 2005, 2008, 2010 
 Residual state and federal spending estimates from US 
Census of Governments and Consolidated Federal Funding 
Report 
 Community characteristics obtained from Census and Area 
Resource File (ARF) 
 Community mortality data obtained from CDC’s Compressed 
Mortality File 
 HSA-level medical care spending data from CMS and 
Dartmouth Atlas (Medicare claims data)  
 
Analytical approach 
 Dependent variables 
– Age-adjusted mortality rates, conditions sensitive  
to public health interventions 
– Medical care spending per recipient (Medicare as proxy) 
 Independent variables of interest 
– Local PH spending per capita, all sources 
– Residual state spending per capita  
(funds not passed thru to local agencies) 
– Residual federal spending per capita 
 Analytic strategy for panel data: 1993-2008 
– Fixed effects estimation 
– Random effects with instrumental variables (IV) 
Analytical approach: IV estimation 
 Identify exogenous sources of variation in 
spending that are unrelated to outcomes 
– Governance structures: local boards of health 
– Decision-making authority: agency, board, local, state 
 Controls for unmeasured factors that jointly 
influence spending and outcomes 
PH spending 
Mortality/ 
Medical $ 
Unmeasured  
disease burden, 
risk 
Unmeasured  
economic  
conditions 
Governance/ 
Decision-making 
Analytical approach 
 Semi-logarithmic multivariate regression models used 
to test associations between spending, service delivery, 
and outcomes while controlling for other factors 
 
Ln(PH$ijt) = βAgencyijt+δCommunityijt+λStatejt+µj+ϕt+εijt 
  
Ln(Mortalityijt) = αLn(PH$ijt) 
+βAgencyijt+δCommunityijt+λStatejt+µj+ϕt+εijt 
 
Ln(Medical$ijt) = αLn(PH$ijt) 
+βAgencyijt+δCommunityijt+λStatejt+µj+ϕt+εijt 
 
∧ 
∧ 
Sensitivity analyses using 1, 3, and 5 year lag structures 
Analytical approach 
 Agency characteristics: type of government jurisdiction, 
scope of services offered, local governance and decision-
making structures 
 Community characteristics: population size, rural-urban, 
poverty, income per capita, education attainment, 
unemployment, age distributions, physicians per capita, CHC 
funding per low income, health insurance coverage, local 
health care wage index 
 State characteristics: Private insurance coverage, Medicaid 
coverage, state fixed effects 
 
Other Variables Used in the Models 
Variation in Local Public Health Spending 
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Determinants of Local Public Health 
Spending Levels: IVs 
                 
 Governance/Decision Authority       Coefficient       95% CI 
Governed by local board of health   0.131** (0.061, 0.201) 
State hires local PH agency head†      -0.151*  (-0.318, 0.018) 
Local govt approves local PH budget†     -0.388*** (-0.576, -0.200) 
State approves local PH budget†  -0.308** (-0.162, -0.454) 
Local govt sets local PH fees    0.217** (0.101, 0.334) 
Local govt imposes local PH taxes   0.190** (0.044, 0.337) 
Local board can request local PH levy  0.120** (0.246, 0.007) 
log regression estimates controlling for community-level and state-level 
characteristics.    *p<0.10            **p<0.05           ***p<0.01 
†As compared to the local board of health having the authority.   
Elasticity 
F=13.4  p<0.001 
Determinants of Local Public Health 
Spending Levels 
– Delivery system size & structure 
– Service mix 
– Population needs and risks 
– Efficiency & uncertainty 
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Mays et al. 2009 
Multivariate estimates of public health 
spending effects on mortality 1993-2008 
*p<0.10        **p<0.05     ***p<0.01 
Cross-sectional 
model 
Fixed-effects 
 model IV  model 
Residual 
Outcome Elasticity St. Err. Elasticity St. Err. Elasticity St. Err. 
Infant mortality 0.0516 0.0181 ** 0.0234 0.0192 -0.1437 0.0589 *** 
Heart disease -0.0003 0.0051 -0.0103 0.0040 ** -0.1881 0.0292 ** 
Diabetes 0.0323 0.0187 -0.0487 0.0174 *** -0.3015 0.0633 ** 
Cancer 0.0048 0.0029 * -0.0075 0.0240 -0.0532 0.0166 ** 
Influenza -0.0400 0.0200 ** -0.0275 0.0107 ** -0.4320 0.0624 
Alzheimer’s 0.0024 0.0075 0.0032 0.0047 0.0028 0.0311 
0.0007 0.0083 0.0004 0.0031 0.0013 0.0086 
** 
log regression estimates controlling for community-level and state-level characteristics 
Effects of public health spending  
on medical care spending 1993-2008 
Model Elasticity Std. Error 
Fixed effects -0.010 0.002 
Instrumental variables -0.088 0.013 
** 
** 
log regression estimates controlling for community-level and state-level characteristics 
*p<0.10        **p<0.05     ***p<0.01 
Change in Medical Care Spending Per Capita Attributable to  
1% Increase in Public Health Spending Per Capita 
Projected effects of ACA  
public health spending 
 10% increase in public health spending in 
average community: 
 
Public health cost  $594,291 
Medical cost offset        -$515,114  (Medicare only) 
LY gained            148 
Net cost/LY          $534 
 
Conclusions 
 Local public health spending varies widely 
across communities 
 Communities with higher spending experience 
lower mortality from leading preventable causes 
of death 
 Growth in local public health spending appears 
to offset growth in medical care spending 
 
Implications for Policy and Practice 
 Mortality reductions achievable through 
increases in public health spending may equal or 
exceed the reductions produced by similar 
expansions in local medical care resources 
 Increased federal investments may help to 
reduce geographic disparities in population 
health and bend the medical cost curve.   
 Gains from federal investments may be offset by 
reductions in state and local spending   
 
Limitations and next steps 
 Aggregate spending measures 
– Average effects 
– Role of allocation decisions? 
 Mortality – distal measures with long  
incubation periods 
 Medical care spending relies on Medicare  
as a proxy measure (20% of total medical $) 
 Ongoing exploration of lag structures 
 
Some more questions of interest… 
 How can we derive greater value from public 
health expenditures? 
 Are there economies of scale and scope in the 
delivery of public health services? 
 Can regionalization improve availability, efficiency 
& effectiveness of public health services? 
Local public health delivery systems 
Source: 2010 NACCHO National Profile of Local Health Departments Survey 
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Sources of Scale and Scope Effects 
Economies of Scale 
 Spread fixed costs of public health activities 
 Allow specialization of labor and capital 
 Enhance predictability of infrequent events 
 Pool surge capacity 
 Learn by doing 
 Internalize spill-over effects 
 Network effects 
Economies of Scope 
 Use common infrastructure for multiple activities 
 Cross-train workforce 
 Realize synergies across activities  
 Network effects 
Analytic Approach 
 Estimate the effects of scale (population served)  
and scope (array of activities delivered) on: 
– public health expenditures 
– health outcomes (preventable mortality) 
 Address the potential endogeneity of scope, quality 
 Simulate the effects of regionalizing jurisdictions that 
fall below selected population thresholds 
 <25,000 
 <50,000 
 <100,000 
 <150,000 
 
Data used in empirical work 
 National Longitudinal Survey of Public Health Systems 
 Cohort of 360 communities with at least 100,000 residents 
 Followed over time: 1998, 2006, 2012 
 Measures: 
– Scope: availability of 20 public health activities 
– Effort: contributed by the local public health agency 
– Quality: perceived effectiveness of each activity 
– Network: organizations contributing to each activity 
 Linked with data from NACCHO Profile 
– Scale: population size served 
– Cost: Local public health agency expenditures 
– Agency characteristics 
Data used in empirical work 
 Survey data linked with secondary sources of area 
characteristics (Census, ARF) 
 Small sample of jurisdictions under 100,000 (n=36)  
used to evaluate prediction accuracy 
 
Analytical approach 
Cost Function Model (semi trans-log) 
Ln(Costijt) = α1Scaleijt+ α2Scale2ijt+ β1Scopeijt+β2Scope2ijt+ 
φ1Qualityijt+ φ2Quality2ijt+ λXijt+ µj+ϕt+εijt 
 
Instrumental Variables Model 
Scopeijt = θNetworkijt+λAgencyijt+ δCommunityijt+ µj+ϕt+εijt 
Qualityijt = θNetworkijt+λAgencyijt+ δCommunityijt+ µj+ϕt+εijt 
 IVs: Network: degree centrality, average path length 
 
All models control for type of jurisdiction, governance structure, centralization, 
population density, metropolitan area designation, income per capita, unemployment, 
racial composition, age distribution, educational attainment, physician and hospital 
availability   
Results: Scale and Scope Estimates 
Partial Elasticity 
Variable Coeff. S.E. 
Population size 0.0184 0.0029 *** 
Population size squared -0.0014 0.0002 *** 
Scope 3.89 1.41 *** 
Scope squared -2.58 0.99 *** 
Quality -2.98 1.39 ** 
Quality squared 2.72 1.23 ** 
**p<0.05   ***p<0.01 
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Conclusions 
 Significant scale and scope effects are apparent 
in local public health production 
 Gains from regionalization may accrue through 
efficiency, scope, and quality 
 Largest regionalization gains accrue to smallest 
jurisdictions 
 If savings are re-invested in public health 
production, possibility of important health gains 
 
Limitations and next steps 
 Limited data on small jurisdictions  
 Inability to observe existing “shared service” 
arrangements 
 Aggregated cost data 
 Lack of data on service volume/intensity 
 
